Inventor · disambiguated record
Dimitrios Stefanidis
Also filed as: STEFANIDIS DIMITRIOS
25 granted patents·14 pending applications·385 citations·filing 2005–2024
96Inventor score
Files withGILEAD PHARMASSET LLC16GILEAD SCIENCES INC9GILEAD CONNECTICUT INC6ROCHE PALO ALTO LLC4AHMED HASHIM A1
Top patents by PatentIndex Score
39 records- 0197US10654827B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2018·Granted May 19, 2020·24 cites·15 claims
- 0297US10071985B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2017·Granted Sep 11, 2018·43 cites·25 claims
- 0395US9549941B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2014·Granted Jan 24, 2017·39 cites·23 claims
- 0495US8889159B2Compositions and methods for treating hepatitis C virusGILEAD PHARMASSET LLC·Filed 2012·Granted Nov 18, 2014·114 cites·37 claims
- 0593US11993583B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted May 28, 2024·3 cites·3 claims
- 0691US10086011B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Granted Oct 2, 2018·8 cites·19 claims
- 0791US9757406B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Sep 12, 2017·9 cites·16 claims
- 0891US9382256B2Formulation of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted Jul 5, 2016·17 cites·57 claims
- 0991US7795237B2Pharmaceutical composition and processAHMED HASHIM A·Filed 2006·Granted Sep 14, 2010·66 cites·14 claims
- 1090US11707479B2Combination formulation of two antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Jul 25, 2023·1 cites·34 claims
- 1190US11116783B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2020·Granted Sep 14, 2021·2 cites·58 claims
- 1288US9949932B2Formulation of syk inhibitorsGILEAD CONNECTICUT INC·Filed 2016·Granted Apr 24, 2018·8 cites·14 claims
- 1388US9657023B2Polymorph of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted May 23, 2017·12 cites·9 claims
- 1487US10266539B2Polymorph of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Granted Apr 23, 2019·7 cites·19 claims
- 1586US11944611B2Capsid inhibitors for the treatment of HIVGILEAD SCIENCES INC·Filed 2019·Granted Apr 2, 2024·11 cites·34 claims
- 1685US9918939B2Formulation of Syk inhibitorsGILEAD CONNECTICUT INC·Filed 2014·Granted Mar 20, 2018·8 cites·23 claims
- 1783US7666891B2Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2005·Granted Feb 23, 2010·6 cites·5 claims
- 1883US2024376077A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 1982US12502394B2Pharmaceutical compositions comprising a JAK inhibitorALFASIGMA SPA·Filed 2024·Granted Dec 23, 2025·0 cites·14 claims
- 2076US7288542B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2005·Granted Oct 30, 2007·3 cites·36 claims
- 2175US10039779B2Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted Aug 7, 2018·1 cites·16 claims
- 2274US2020188419A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2019·Application pending·0 cites
- 2372US7893037B2Pharmaceutical composition and processROCHE PALO ALTO LLC·Filed 2008·Granted Feb 22, 2011·3 cites·12 claims
- 2471US11975008B2Pharmaceutical compositions comprising a JAK inhibitorGALAPAGOS NV·Filed 2021·Granted May 7, 2024·0 cites·12 claims
- 2564US2019240246A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Application pending·0 cites
- 2662US2015064253A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 2761US2019111068A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2018·Application pending·0 cites
- 2860US2014212491A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 2958US2017348342A1Compositions and methods for treating hepatitis c virusGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 3056US10912814B2Combination formulation of three antiviral compoundsGILEAD PHARMASSET LLC·Filed 2017·Granted Feb 9, 2021·0 cites·2 claims
- 3156US2009218708A1Process for preparing concentrated aqueous micellar solutionsROCHE PALO ALTO LLC·Filed 2009·Application pending·0 cites
- 3253US11338007B2Combination formulation of three antiviral compoundsGILEAD SCIENCES INC·Filed 2017·Granted May 24, 2022·0 cites·44 claims
- 3353US2014212487A1Solid dispersion formulation of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 3453US2016120892A1Combination formulation of two antiviral compoundsGILEAD PHARMASSET LLC·Filed 2015·Application pending·0 cites
- 3552US2018263997A1Pharmaceutical compositions comprising a jak inhibitorGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3652US2015064252A1Solid dispersion formulation of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Application pending·0 cites
- 3750US2017217967A1Polymorph of syk inhibitorsGILEAD CONNECTICUT INC·Filed 2017·Application pending·0 cites
- 3845US2022296619A1Pharmaceutical formulations of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 3943US8293778B2Heterocyclic antiviral compoundsDUNN JAMES PATRICK·Filed 2010·Granted Oct 23, 2012·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Dimitrios Stefanidis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →